Cilgavimab

REQUEST MORE INFO
Catalogue No: abx831615
Price: US$406.00
(Size: 100 µg)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Cilgavimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SARS-CoV-2 Spike RBD, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Target SARS-CoV-2 Spike RBD
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA, WB
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Buffer 0.01 M PBS. pH 7.4.
CAS Number 2420563-99-9
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 7-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on SARS-CoV-2 Spike RBD


Write a review

Tags:
(Click to show)